AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283 | -36.8% | 4,040 | -30.4% | 0.03% | -37.8% |
| Q4 2022 | $448 | -99.9% | 5,802 | -37.0% | 0.04% | +9.8% |
| Q3 2022 | $411,000 | +101.5% | 9,210 | +71.1% | 0.04% | +78.3% |
| Q4 2021 | $204,000 | -36.1% | 5,382 | -4.3% | 0.02% | -36.1% |
| Q1 2021 | $319,000 | -22.4% | 5,626 | +12.5% | 0.04% | -41.9% |
| Q2 2020 | $411,000 | +45.7% | 4,999 | +83.2% | 0.06% | +37.8% |
| Q4 2019 | $282,000 | -40.8% | 2,728 | -88.4% | 0.04% | -46.4% |
| Q3 2019 | $476,000 | +632.3% | 23,506 | -11.2% | 0.08% | +740.0% |
| Q1 2018 | $65,000 | – | 26,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |